Neurocysticercosis: Association between seizures, serology, and brain CT in rural Peru

Neurology

Volumn 65, Issue 2, 2005, Pages 229-234

  Montano, S M ^a,b   Villaran, M V ^a   Ylquimiche, L ^a   Figueroa, J J ^a   Rodriguez, S ^b   Bautista, C T ^c   Gonzalez, A E ^b,d   Tsang, V C W ^e   Gilman, R H ^a,d   Garcia, H H ^a,b,d  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^c Henry M Jackson Foundation Inc   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; NEUROIMAGING; PERU; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SEIZURE; SEROLOGY;

EID: 22544441152     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000168828.83461.09     Document Type: Article

References (42)

1. Garcia HH, Gonzalez AE, Evans CAW, Gilman RH, Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet 2003;362:547-556.
2. Schantz PM, Wilkins PP, Tsang VCW Immigrants, imaging and immunoblots: the emergence of neurocysticercosis as a significant public health problem. In: Scheld WM, Craig WA, Hughes JM, eds. Emerging infections 2. Washington, DC: ASM Press, 1998:213-241.
3. Tsang V, Wilson M. Taenia solium cysticercosis, an under-recognized but serious public health problem. Parasitol Today 1995;11:124-126.
4. Garcia HH, Gilman RH, Gonzalez AE, et al. Hyperendemic human and porcine Taenia solium infection in Peru. Am J Trop Med Hyg 2003;68: 268-275.
5. Bern C, Garcia HH, Evans C, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 1999; 29:1203-1209.
6. Commission on Tropical Diseases of the International League Against Epilepsy. Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy. Epilepsia 1994; 35:89-93.
7. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002;2:751-762.
8. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998;39:1025-1040.
9. Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000;68:137-143.
10. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989;159:50-59.
11. Placencia M, S JW, Shorvon SD, Ellison RH, Cascante SM. Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain 1992;115:783-794.
12. Placencia M, Suarez J, Crespo F, et al. A large-scale study of epilepsy in Ecuador: methodological aspects. Neuroepidemiology 1992;11:74-84.
13. Del Brutto OH, Santibáñez R, Idrovo L. et al. Epilepsy and neurocysticercosis in Atahualpa. A door-to-door survey in rural coastal Ecuador. Epilepsia 2005;46:583-587.
14. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22: 489-501.
15. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
16. Sanders JW, Shorvon S. The epilepsies. In: Martin CN, Hughes RAC, editors. The epidemiology of neurological disorders. London: BMJ Books, 1998: 138-167.
17. Garcia HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Tropica 2003;87:71-78.
18. Szklo M, Nieto FJ. Epidemiology. Beyond the basics. Gaithersburg, MD: Aspen, 2000.
19. Senanayake N, Roman GC. Epidemiology of epilepsy in developing countries. Bull WHO 1993;71:247-258.
20. Rocca WA, Savettieri G, Anderson DW, et al. Door-to-door prevalence survey of epilepsy in three Sicilian municipalities. Neuroepidemiology 2001;20:237-241.
21. Sidenvall R, Forsgren L, Heijbel J. Prevalence and characteristics of epilepsy in children in northern Sweden. Seizure 1996;5:139-146.
22. Luengo A, Parra J, Colas J, et al. Prevalence of epilepsy in northeast Madrid. J Neurol 2001;248:762-767.
23. Nakashima K, Yokoyama Y, Shimoyama R, et al. Prevalence of neurological disorders in a Japanese town. Neuroepidemiology 1996;15:208-213.
24. Hauser WA, Hesdorffer DH. Epilepsy: frequency, causes, and consequences. New York: Cemos Press, 1990.
25. Koul R, Razdan S, Motta A. Prevalence and pattern of epilepsy (Lath/ Mirgi/Laran) in rural Kashmir, India. Epilepsia 1988;29:116-122.
26. Gerrits C. Epilepsy care in a non-clinical setting. A medical-anthropological study among the Bassa and Kpelle in the rainforest of Liberia, West Africa. Trop Geogr Med. 1994;46(suppl):S13-S17.
27. Mendizabal JE, Salguero LF. Prevalence of epilepsy in a rural community of Guatemala. Epilepsia 1996;37:373-376.
28. Garcia-Noval J, Moreno E, de Mata F, et al. An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol 2001;95:167-175.
29. Placencia M, Sander JW, Roman M, et al. The characteristics of epilepsy in a largely untreated population in rural Ecuador. J Neurol Neurosurg Psychiatry 1994;57:320-325.
30. Placencia M, Shorvon SD, Paredes V, et al. Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain. 1992;115:771-782.
31. Borges MA, Min LL, Guerreiro CA, et al. Urban prevalence of epilepsy: populational study in Sao Jose do Rio Preto, a medium-sized city in Brazil. Ar Qneuropsiquiatr. 2004;62:199-204.
32. Nicoletti A, Reggio A, Bartoloni A, et al. Prevalence of epilepsy in rural Bolivia: a door-to-door survey. Neurology 1999;53:2064-2069.
33. Gomez JG, Arciniegas E, Torres J. Prevalence of epilepsy in Bogota, Colombia. Neurology 1978;28:90-94.
34. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996;71:576-586.
35. Garcia HH, Gilman RH, Catacora M, et al. Serological evolution of neurocysticercosis patients after antiparasitic therapy. J Infect Dis 1997;175:486-489.
36. Cruz ME, Schantz PM, Cruz I, et al. Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol 1999;28:799-803.
37. Sanchez AL, Lindback J, Schantz PM, et al. A population-based, case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol 1999;93:247-258.
38. Schantz PM, Sarti E, Plancarte A, et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis 1994;18:879-885.
39. Fleury A, Gomez T, Alvarez I, et al. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 2003;22:139-145.
40. Morales-Montor J, Chavarria A, De Leon MA, et al. Host gender in parasitic infections of mammals: an evaluation of the female host supremacy paradigm. J Parasitol 2004;90:531-546.
41. Garcia HH, Gonzalez AE, Gilman RH, for the Cysticercosis Working Group in Peru. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis 2003;16:411-419.
42. Roman G, Sotelo J, Del Brutto O. et al. A proposal to declare neurocysticercosis an international reportable disease. Bull WHO 2000;78:399-406.